HALO logo
halo search icon
Annexon, Inc.

US$5.04

Price Change Indicator
0.13 (2.65%)
Annexon, Inc.
ANNX · NAS

Annexon, Inc.

Start Trading ANNX for Free

US$5.04

Price Arrow0.13 (2.65%)
20/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusFakey Shakey - LongFakey Shakey - Long (Realtime)HALO AllHALO Consensus ValueHALO Earnings MomentumHALO Momentum+1
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Annexon, Inc. Overview

ANNX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Very Strong

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Strong

About ANNX

icon
icon

Telephone

1.650.822.5500

icon

Address

Suite 200, Building C, 1400 Sierra Point Parkway, Brisbane, CA 94005

Description

Annexon, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain. It offers drugs that control or target huntington’s and alzheimer’s disease, multiple sclerosis, glaucoma, parkinson’s disease, and spinal muscular atrophy. The company was founded by Ben Barres and Arnon Rosenthal on March 3, 2011 and is headquartered in Brisbane, CA.

ANNX Price Chart

Key Stats

Market Cap

US$804.47M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.85 - 7.18

Trade Value (12mth)

US$2,399,375.00

1 week

-5.76%

1 month

-20.81%

YTD

4.69%

1 year

149.24%

All time high

38.01

Key Fundamentals

EPS 3 yr Growth

-48.20%

EBITDA Margin

0.00%

Operating Cashflow

-$186m

Free Cash Flow Return

-67.20%

ROIC

-74.60%

Interest Coverage

0.00

Quick Ratio

5.70

Other Data

Shares Outstanding (Fully Diluted)

194m

HALO Sector

Healthcare

Next Company Report Date

08-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

ANNX Announcements

Latest Announcements

DateAnnouncements
08 May 26
08 May 26
08 May 26
31 March 26
31 March 26

ANNX Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-1.77-1.01-1.34locklocklock
EPS (Fully Diluted)
 $locklocklocklock-1.77-1.01-1.34locklocklock
Growth
 %locklocklocklock31.743.3-33.7locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Annexon, Inc. (ANNX:NAS)?
Halo FAQ
The current share price of Annexon, Inc. (ANNX:NAS) is USD$5.04.
What is the 52-week high share price for Annexon, Inc. (ANNX:NAS)?
Halo FAQ
The 52-week high share price for Annexon, Inc. (ANNX:NAS) is USD$7.18.
What is the 52-week low share price for Annexon, Inc. (ANNX:NAS)?
Halo FAQ
The 52-week low share price for Annexon, Inc. (ANNX:NAS) is USD$1.85.
What is the dividend yield for Annexon, Inc. (ANNX:NAS)?
Halo FAQ
Annexon, Inc. (ANNX:NAS) does not pay a dividend.
What was Annexon, Inc. (ANNX:NAS) last dividend payment?
Halo FAQ
Annexon, Inc. (ANNX:NAS) does not pay a dividend.
What is the franking level for Annexon, Inc. (ANNX:NAS)?
Halo FAQ
Annexon, Inc. (ANNX:NAS) has a franking level of 0.00%.
In which sector is Annexon, Inc. (ANNX:NAS) classified?
Halo FAQ
Annexon, Inc. (ANNX:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial